Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

In a groundbreaking development that could revolutionise cancer treatment, researchers have advanced an mRNA-based vaccine ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...

The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

Findings from a study on the role of exosomal non-coding RNAs (ncRNAs) in the progression of multiple myeloma (MM), with a specific focus on sex-based differences, show that while male and female ...

Molecular discoveries may help improve treatments for labor and pain. When labor starts, the uterus must produce steady, ...

MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.

Researchers have used an experimental mRNA therapy to make old immune cells in mice behave as if they were young again, ...

A trio of mRNA molecules could help guard against the harmful effects of aging on immune cells, a study in mice finds. A new ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...

Research on mRNA vaccines have been under fire in the post-pandemic age, but these immunotherapies are showing promise in the ...